Deadline: May 1st, 2023

BREAKTHROUGH RESEARCH WAS AND IS THE KEY TO UNDERSTANDING AND SOLVING THE GREATEST CHALLENGES OF OUR TIME

“Ultimately, the goal is to bring health-innovations Made in Europe to the marketplace.”

Large-scale study shows that DX-ICD systems together with Home Monitoring allow for reliable guideline-recommended monitoring of subclinical AF

Glycotope Presents Glyco-Engineered Cell Lines at the 2023 American Association for Cancer Research (AACR) Meeting

Genes are not the only drivers of evolution. The iconic fins of skates are caused by changes in the non-coding parts of the genome and its three-dimensional structure, a research team including Darío Lupiáñez at the Max Delbrück Center reports in…

Berlin, 12 April 2023 – Eckert & Ziegler’s fully owned subsidiary Qi Kang Medical Technology Ltd. (QKM) has recently received the authorization for its Environmental Impact Assessment (EIA) from the Department of Ecology and Environment of Jiangsu…

Berlin, Germany and Indianapolis, Indiana, USA – 4 April 2023 – Eckert & Ziegler (ISIN DE0005659700, TecDAX) and a subsidiary of POINT Biopharma Global Inc. (“POINT”, NASDAQ: PNT) have signed an agreement on the supply of Actinium-225…

Critically ill COVID-19 patients often have antibodies in their blood that bind to the body’s own structures, so-called autoantibodies. Scientists from the BIH at Charité and the Max Delbrück Center have now discovered that these autoantibodies…

Since the beginning of the COVID-19 pandemic, researchers have been working on mucosal vaccines that can be administered through the nose. Now, scientists in Berlin, including researchers from Charité – Universitätsmedizin Berlin, have developed and…

We proudly announce the Speed Lecture Award finalists in 2023 that had been selected by the jury. Congratulations to all of them and good luck for your final performance on May 16th at Ludwig Erhard Haus in Berlin!